[SCHEDULE 13G/A] Exagen Inc. SEC Filing

Rhea-AI Filing Summary

Exagen Inc. reporting person Laurence W. Lytton discloses beneficial ownership of 216,840 shares of common stock, representing 1.0% of the outstanding class. The filing states Mr. Lytton has sole voting and sole dispositive power over these shares, with no shared authority reported.

The statement affirms the shares are not held to influence control of the issuer and the reporting person certifies the accuracy of the disclosure. The filing indicates the position is not part of any group and no other parties are identified as holding power over the securities.

Insights

Securities Analyst

TL;DR Small, disclosed stake: 216,840 shares (1.0%) held with sole voting and dispositive power; limited market impact.

The disclosure shows a non-controlling position by an individual holder with direct control of the shares. At 1.0% of the class, this holding does not meet common materiality thresholds for activism or control attempts. The clear statement of sole voting and dispositive power is procedurally important for transparency but does not signal a strategic change in governance or capital structure based on the information provided.

Corporate Governance Expert

TL;DR Ownership is transparent and certified; no indication of group action or intent to influence issuer control.

The filing identifies the reporting person and documents sole authority over 216,840 shares while explicitly stating the position was not acquired to influence control. For governance monitoring, this is routine disclosure complying with beneficial ownership rules. There is no evidence in the filing of coordinated activity, reliance on derivatives, or other arrangements that would raise governance or control concerns.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

EXAGEN INC.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

30068X103

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 30068X103

1

Names of Reporting Persons

LYTTON LAURENCE W

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 216,840.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 216,840.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

216,840.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Percentage calculated based on 22,003,641 shares of Common Stock outstanding as of July 24, 2025, as reported in the Form 10-Q filed by the issuer on July 29, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: EXAGEN INC.
(b)	Address of issuer's principal executive offices: 1261 Liberty Way, Vista, CA 92081
Item 2.
(a)	Name of person filing: Laurence W. Lytton
(b)	Address or principal business office or, if none, residence: 467 Central Park West New York, NY 10025
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 30068X103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 216,840
(b)	Percent of class: 1.0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 216,840
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 216,840
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LYTTON LAURENCE W

Signature:	/s/ Laurence W. Lytton
Name/Title:	Reporting person
Date:	08/13/2025

FAQ

What stake does Laurence W. Lytton report in Exagen (XGN)?

The filing reports 216,840 shares, representing 1.0% of Exagen's common stock.

Does Laurence W. Lytton have voting control over the shares reported for XGN?

Yes. The filing shows sole voting power and sole dispositive power for the 216,840 shares.

Is the reported position part of a group or held on behalf of another person?

No. The filing states the position is not part of a group and is not held on behalf of another person.

Was the stake acquired to influence control of Exagen (XGN)?

No. The reporting person certifies the securities were not acquired to change or influence control of the issuer.

Who signed the Schedule 13G/A filing for this disclosure?

The filing is signed by the reporting person, identified as Laurence W. Lytton.